2 completed, 1 active not recruiting, 1 terminated. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Active not recruiting 1 |
| Phase 2 | 1 | Terminated 1 |
Follow PPM Services S.A.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Long-term Safety and Efficacy Study of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Subjects With Acne Vulgaris (GEDACNE-LT) N-Acetyl-GED-0507-34-LEVO gel 5% - Acne Vulgaris | Phase 3 | Active not recruiting | PPM Services S.A. | 400 | 2024-12-05 | 2026-09-15 |
| A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5% in Patients With Acne Vulgaris (GEDACNE 2) N-Acetyl-GED-0507-34-Levo, N-Acetyl-GED-0507-34-Levo corresponding vehicle - Acne Vulgaris | Phase 3 | Completed | PPM Services S.A. | 398 | 2024-11-19 | 2026-09-15 |
| A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Patients With Acne Vulgaris (GEDACNE-1) N-Acetyl-GED-0507-34-Levo 5% gel, N-Acetyl-GED-0507-34-Levo corresponding vehicle - Acne Vulgaris | Phase 3 | Completed | PPM Services S.A. | 407 | 2024-11-19 | 2026-09-15 |
| Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC GED-0507-34-Levo 80 mg, GED-0507-34-Levo 160 mg, Placebo - Ulcerative Colitis | Phase 2 | Terminated | PPM Services S.A. | 19 | 2016-11-28 | 2018-11-27 |
Acne Vulgaris (3) · Colitis, Ulcerative (1)
Gels (1)
Italy (4) · Poland (4) · Spain (3) · Bulgaria (1) · Canada (1) · France (1) · Hungary (1) · Latvia (1) · Slovakia (1) · Ukraine (1) · United States (1)
2023 (3)